TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
NBAB, Nordic BioAnalysis AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
10,030
|
8,384
|
4,259 |
Financial expenses |
41
|
6
|
0 |
Earnings before taxes |
-318
|
-945
|
58 |
EBITDA |
-155
|
-1,030
|
104 |
Total assets |
5,537
|
5,277
|
5,447 |
Current assets |
4,788
|
4,890
|
5,179 |
Current liabilities |
2,950
|
2,549
|
1,775 |
Equity capital |
2,409
|
2,728
|
3,672 |
- share capital |
123
![]() |
123
![]() |
123 |
Employees (average) |
8
|
6
|
4 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
43.5%
|
51.7%
|
67.4% |
Turnover per employee |
1,254
|
1,397
|
1,065 |
Profit as a percentage of turnover |
-3.2%
|
-11.3%
|
1.4% |
Return on assets (ROA) |
-5.0%
|
-17.8%
|
1.1% |
Current ratio |
162.3%
|
191.8%
|
291.8% |
Return on equity (ROE) |
-13.2%
|
-34.6%
|
1.6% |
Change turnover |
1,646
|
4,125
|
-3,238 |
Change turnover % |
20%
|
97%
|
-43% |
Chg. No. of employees |
2
![]() |
2
|
0 |
Chg. No. of employees % |
33%
|
50%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.